CSI Market
Sign In | Register
Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Trevena Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Trevena Inc (TRVN) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2024

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/TRVN/competitors
https://api.csimarket.com/api/v1/companies/TRVN/relationships
https://api.csimarket.com/api/v1/companies/TRVN/similar
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Business Relationships API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
AI Integration via MCP
Connect Claude, ChatGPT, or any MCP-compatible AI assistant directly to this data.

Trevena Inc's Competitor Quality Breadth

Group definitions: see Methodology: Performance Group Definitions.

Entity Profitable Expanding Above Industry Growth Distressed
Trevena inc - - - Yes
High-Confidence Competitors (6) 0% 33% 0% 83%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

TRVN Stock Performance relative to its Competitors

TRVN Competitors (weighted) Percent change over the selected range

Trevena Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
66.7%beat U.S.A. 500
High-Confidence
(2 of 3)
Entity TTM Share Price Return
(group: median)		 vs U.S.A. 500
Trevena inc - -
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (3) 40.4% 63.2%
Similar-Size Competitors (0) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Trevena Inc's competitor groups requires a Commercial License.

Unlock Full Access

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

TRVN Stock Performance relative to High-Confidence Competitors

TRVN High-Confidence Competitors (equal-weighted, 7) Percent change over the selected range

Trevena Inc's Comment on Competition and Industry Peers

The competitive landscape for OLINVYK includes products in mid- and late-stage clinical development targeting the treatment of moderate-to-severe acute pain. Avenue Therapeutics, Inc. is developing an intravenous version of the generic opioid tramadol for this indication. The company competes with major pharmaceutical, specialty pharmaceutical, and biotechnology firms, as well as academic institutions, governmental agencies, and public and private research organizations. Competitors may possess greater financial resources and expertise in research and development, manufacturing, clinical trials, regulatory approvals, and marketing. Industry mergers and acquisitions may further concentrate resources among fewer competitors. Additionally, smaller or early-stage companies may also present significant competition.
Competitor data is not yet available for Trevena Inc.

Trevena Inc's Competitors Named by the Company

Competitive relationships identified from Trevena Inc reports and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Avenue Therapeutics, Inc. Company report 85% 2022 to 2026 3
Cumberland Pharmaceuticals Company report 85% 2022 to 2026 3
Mallinckrodt plc Company report 85% 2022 to 2026 3
Baudax Bio, Inc. Company report 85% 2022 to 2026 3
Innocoll Holdings plc Company report 85% 2022 to 2026 3
AcelRx Pharmaceuticals, Inc. Company report 85% 2022 to 2026 3
DURECT Corporation Company report 85% 2022 to 2026 3
Pacira Pharmaceuticals, Inc. Company report 85% 2022 to 2026 3
Heron Therapeutics, Inc. Company report 85% 2022 to 2026 3
Cara Therapeutics Inc. Company report 85% 2022 to 2026 3
Competitor Evidence Detail

Company report basis, confidence, active dates and source counts for Trevena Inc's named competitors require a Commercial License.

Unlock Full Access

Methodology: see Methodology: Peer & Competitor Identification, Sourcing.

On This Page
  1. API & Data Access
  2. Competitor Quality Breadth
  3. Stock Performance
  4. Stock Performance by Peer Group
  5. Comment on Competition
  6. Share Price Performance vs Peer Groups
  7. Competitors Named by the Company
More on TRVN
  1. List of TRVN Competitors
  2. TRVN Stock Performance Comparisons
  3. Market Share
  4. Productivity vs. Peers
Get the full CSIMarket dataset: Subscribe API Connect Your AI